CMB305 and Atezolizumab vs Atezolizumab Alone in Soft-Tissue Sarcomas Expressing NY-ESO-1
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Phase II Randomized Study of CMB305 and Atezolizumab Compared With Atezolizumab Alone in Soft-Tissue Sarcomas Expressing NY-ESO-1
J. Clin. Oncol 2022 Apr 20;40(12)1291-1300, SP Chawla, BA Van Tine, SM Pollack, KN Ganjoo, AD Elias, RF Riedel, S Attia, E Choy, SH Okuno, M Agulnik, M von Mehren, MB Livingston, VL Keedy, CF Verschraegen, T Philip, GC Bohac, S Yurasov, A Yakovich, H Lu, M Chen, RG MakiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.